09.11.2018 Elevian Launches to Develop Regenerative Medicines for Age-Related Diseases Happy to announce our support for Elevian together with BOLD Capital and Peter Diamandis. Commercializing scientific breakthroughs from Elevian’s scientific co-founders. Read more